[1] Feday J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOB0CAN 2012[J].Int J Cancer,2015,136(5):359-386.
[2] Basas M.EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder:up-date 2016[J].Eur Urol,2016,21(2):6-17.
[3] Mauro P.Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory[J].Cell,2019,177(2):414-427.
[4] 杨洪波,石洁,叶勇,李文成,等.COL5A2在膀胱癌组织中的表达及其与临床病理特征和预后的相关性分析[J].实用肿瘤学杂志 ,2019,33(1):52-56.
[5] Tkach M,Thery C.Communication by extracellular vesicles:where we are and where we need to go[J].Cell,2016 ,164(6):1226-1232.
[6] Rashed M,Bayraktar E,Kelal G,et al.Exosomes:From garbage bins to promising therapeutic targets[J]. Int J Mol Sci,2017,18(3):538.
[7] Andreu Z,Otta Oshiro R,Redruello A,et al. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression[J].Eur J Pharm Sci,2017,15(98):70-79.
[8] Xue M,Pang H,Li X,et al.Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway[J].Cancer Sci,2016,107(1):18-27.
[9] Mei X,Wei C,An X,et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1[J].Mol Cancer,2017,16(1):143. |
2021, Vol. 41 
